Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.
Ten antibacterials for systemic use (ATC J01) with the highest consumption in the community sector in Poland, 2024_
| WHO ATC | Antibacterials | DID | % of total | AWaRe | ||
|---|---|---|---|---|---|---|
| 1. | J01C | J01CR02 | amoxicillin-clavulanic-acid | 3.30 | 15.5 | Access |
| 2. | J01X | J01XE03 | furazidin | 3.18 | 15.0 | Access |
| 3. | J01C | J01CA04 | amoxicillin | 2.87 | 13.5 | Access |
| 4. | J01D | J01DC02 | cefuroxime | 2.40 | 11.3 | Watch |
| 5. | J01F | J01FA10 | azithromycin | 2.33 | 10.1 | Watch |
| 6. | J01F | J01FA09 | clarithromycin | 1.97 | 9.3 | Watch |
| 7. | J01A | J01AA02 | doxycycline | 1.39 | 6.5 | Access |
| 8. | J01F | J01FF01 | clindamycin | 0.83 | 3.9 | Access |
| 9. | J01M | J01MA02 | ciprofloxacin | 0.61 | 2.8 | Watch |
| 10. | J01M | J01MA12 | levofloxacin | 0.44 | 2.1 | Watch |